Published in Oxid Med Cell Longev on January 12, 2017
Role of the Enterocyte in Fructose-Induced Hypertriglyceridaemia. Nutrients (2017) 0.75
The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease. J Clin Med (2017) 0.75
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol (2008) 3.24
Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry (2002) 2.80
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA (2014) 2.75
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol (2004) 2.62
Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. J Nutr (2014) 2.58
The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med (2016) 2.31
Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc (2004) 2.28
Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res (2004) 2.23
Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging (2001) 2.20
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol (2006) 2.16
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta (2014) 2.09
Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc (2010) 2.09
Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem (2007) 2.09
RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J (2004) 2.08
The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry (2008) 2.06
Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci (2007) 2.04
Milk and dairy consumption and risk of dementia in an elderly Japanese population: the Hisayama Study. J Am Geriatr Soc (2014) 2.02
Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr (2002) 1.91
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol (2001) 1.89
Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology (2012) 1.66
Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem (2003) 1.64
Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging (2010) 1.61
Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci (2014) 1.57
Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol (2005) 1.56
Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol (2014) 1.52
The genetics of extreme longevity: lessons from the new England centenarian study. Front Genet (2012) 1.51
Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol (2013) 1.50
Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des (2010) 1.50
Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol (2003) 1.48
Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis (2006) 1.45
Dietary advanced glycation endproducts (AGEs) and their health effects--PRO. Mol Nutr Food Res (2007) 1.41
Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol (2009) 1.38
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging (2014) 1.28
Physical activity, brain plasticity, and Alzheimer's disease. Arch Med Res (2012) 1.27
Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev (2005) 1.23
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol (2008) 1.18
n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc (2013) 1.17
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol (2013) 1.15
Berry fruit supplementation and the aging brain. J Agric Food Chem (2008) 1.12
Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Res Bull (2011) 1.10
Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis (2007) 1.10
The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis (2012) 1.10
Lifestyle change and the prevention of cognitive decline and dementia: what is the evidence? Curr Opin Psychiatry (2013) 1.09
Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis (2006) 1.09
Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging (2006) 1.05
Inhibition of protein glycation by extracts of culinary herbs and spices. J Med Food (2008) 1.04
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A (2014) 1.04
Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev (2012) 1.03
RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim Biophys Acta (2005) 1.02
The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res (2010) 1.01
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev (2011) 1.00
RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J Cell Sci (2010) 1.00
The impact of flavonoids on spatial memory in rodents: from behaviour to underlying hippocampal mechanisms. Genes Nutr (2009) 0.99
The metal theory of Alzheimer's disease. J Alzheimers Dis (2013) 0.98
Green tea polyphenols and their potential role in health and disease. Inflammopharmacology (2015) 0.98
Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. Free Radic Res (2013) 0.96
The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiol Aging (2011) 0.91
Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines. Metab Brain Dis (2014) 0.90
Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study. Am J Clin Nutr (2013) 0.90
Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol (2011) 0.89
Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuro Endocrinol Lett (2003) 0.88
Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease. J Clin Neurosci (2012) 0.88
Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study. J Intern Med (2014) 0.88
Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res (2011) 0.87
Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging. Aging Dis (2014) 0.87
Vitamin A has anti-oligomerization effects on amyloid-β in vitro. J Alzheimers Dis (2011) 0.86
Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules (2014) 0.85
Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One (2012) 0.85
The Complexity of Sporadic Alzheimer's Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction. Int J Alzheimers Dis (2012) 0.85
n-3 LCPUFA improves cognition: the young, the old and the sick. Prostaglandins Leukot Essent Fatty Acids (2014) 0.85
Associations between Alzheimer's disease and blood homocysteine, vitamin B12, and folate: a case-control study. Curr Alzheimer Res (2015) 0.84
Chronic consumption of flavanone-rich orange juice is associated with cognitive benefits: an 8-wk, randomized, double-blind, placebo-controlled trial in healthy older adults. Am J Clin Nutr (2015) 0.84
Strategy for the study of the health impact of dietary Maillard products in clinical studies: the example of the ICARE clinical study on healthy adults. Ann N Y Acad Sci (2008) 0.84
Slowing the progression of Alzheimer's disease; what works? Ageing Res Rev (2015) 0.83
Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease. Exp Mol Med (2014) 0.82
Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence. J Alzheimers Dis (2015) 0.81
The impact of alcohol on Alzheimer's disease: a systematic review. Aging Ment Health (2012) 0.81
Dietary advanced glycation end products and their role in health and disease. Adv Nutr (2015) 0.81
Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease. J Neurol Sci (2016) 0.80
A role for hippocampal PSA-NCAM and NMDA-NR2B receptor function in flavonoid-induced spatial memory improvements in young rats. Neuropharmacology (2013) 0.80
Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia. Ann Agric Environ Med (2015) 0.80
Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics. Int J Alzheimers Dis (2015) 0.79
Vitamin E: Curse or Benefit in Alzheimer's Disease? A Systematic Investigation of the Impact of α-, γ- and δ-Tocopherol on Aß Generation and Degradation in Neuroblastoma Cells. J Nutr Health Aging (2015) 0.79
The potential role of nutritional components in the management of Alzheimer's Disease. Eur J Pharmacol (2008) 0.79
The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease. Int J Alzheimers Dis (2014) 0.78
Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain. Nutrition (2013) 0.78
Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key? Histol Histopathol (2014) 0.78
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach. Cell Mol Biol Lett (2014) 0.78
Dietary Polyphenol Supplementation Prevents Alterations of Spatial Navigation in Middle-Aged Mice. Front Behav Neurosci (2016) 0.77
Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects? Neurochem Int (2015) 0.77
Do statins prevent Alzheimer's disease? A narrative review. Eur J Intern Med (2015) 0.77
Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia. Eur J Pharmacol (2015) 0.77
Do omega-3 fats boost brain function in adults? Are we any closer to an answer? Am J Clin Nutr (2013) 0.77
Using Multicountry Ecological and Observational Studies to Determine Dietary Risk Factors for Alzheimer's Disease. J Am Coll Nutr (2016) 0.77
An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Med (2012) 0.76
Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease. Mol Neurodegener (2016) 0.76
Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases. Autism Res (2017) 0.75
Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action. Healthcare (Basel) (2020) 0.75